{"cluster": 20, "subcluster": 28, "abstract_summ": "While severe COVID-19 patients develop a strong antibody response, mild SARS-CoV-2 infections induce a modest antibody response.Results: We found that only patients with relative persistence of virus at pharynx displayed strong antibody responses that were proportional to the pharyngeal viral load.Strong antibody response contains more inefficient and maybe even harmful antibodies.Although antibody levels decreased around 2 weeks after symptom onset, the neutralization efficacy per unit antibody remained steady and even continued to increase over time.Severe patients (n=38) develop a robust antibody response to SARS-CoV-2, including IgG and IgA antibodies.", "title_summ": "Quantifying antibody kinetics and RNA shedding during early-phase SARS-CoV-2 infectionIntrafamilial Exposure to SARS-CoV-2 Induces Cellular Immune Response without SeroconversionRelative COVID-19 viral persistence and antibody kineticsSystemic and mucosal antibody secretion specific to SARS-CoV-2 during mild versus severe COVID-19Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infectionCharacterization of anti-viral immunity in recovered individuals infected by SARS-CoV-2IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individualsMagnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severityDifferences in antibody kinetics and functionality between severe and mild SARS-CoV-2 infections.SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy.The Dynamic Changes of Antibodies against SARS-CoV-2 during the Infection and Recovery of COVID-19Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals", "title_abstract_phrases": "While severe COVID-19 patients develop a strong antibody response, mild SARS-CoV-2 infections induce a modest antibody response.Magnitude and kinetics of anti-SARS-CoV-2 antibody responses and their relationship to disease severityBackground: SARS-CoV-2 infection can be detected indirectly by measuring the host immune response.Strong antibody response contains more inefficient and maybe even harmful antibodies.Results: We found that only patients with relative persistence of virus at pharynx displayed strong antibody responses that were proportional to the pharyngeal viral load.Although antibody levels decreased around 2 weeks after symptom onset, the neutralization efficacy per unit antibody remained steady and even continued to increase over time."}